METHODS	In a placebo-controlled , double-blind , randomized , multicentric clinical trial , 162 healthy participants with recurring infections received 900 mg of either placebo ( n = 81 ) or an insoluble yeast ( 1,3 ) - ( 1,6 ) - beta-D-glucan preparation ( n = 81 ) per day over a course of 16 weeks .\